Live news related to ABL Diagnostics stock (FR001400AHX6): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on ABL Diagnostics mainly cover M&A activity, the dividend and payout policy et earnings publications. The stock trades at €2,50 on Euronext Paris at the last update. This page lists the articles published on ABL Diagnostics stock to track the share price, company announcements and any item likely to influence market perception.
ABL Diagnostics approved a dividend of €0.11 per share for the fiscal year 2025 on June 30, up from €0.05 paid for 2024, reflecting improved results a…
Invest Securities reaffirms its positive outlook on ABL Diagnostics and raises its price target, citing expected growth acceleration from 2026 and mar…
The stock of the molecular diagnostics company is regaining ground in this Friday's session, supported by the announcement of a new multi-year commerc…
ABL Diagnostics announced on Friday the signing of a multi-year agreement with a European pharmaceutical company specializing in neurodegenerative dis…
On Tuesday, June 9, ABL Diagnostics submitted a takeover offer to the Evry Commercial Court to acquire the business and assets of Texcell, a company s…
The molecular diagnostics company announced on Monday a major acceleration in its growth, driven by the technological integration completed in 2025 an…
ABL Diagnostics announces the signing of a non-binding letter of intent between its controlling shareholder ABL S.A. and the Nasdaq-listed American co…
